Lung Cancer Clinical Trials in Houston

Showing 261-280 of 620 trials

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

NCT06010329

The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC (uncommon EGFR mutations only).

Non-small Cell Lung Cancer

Teligene US66 participantsStarted Dec 2023

Glendale, California, United States • La Jolla, California, United States • Tampa, Florida, United States +6 more locations

TERMINATEDPhase 1/2< 1 mile

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

NCT05543629

The purpose of this study is to evaluate BMS-986442 in combination with nivolumab (with or without chemotherapy) for its antitumor efficacy and benefit to participants.

Advanced Solid TumorsNon-small Cell Lung Cancer

Bristol-Myers Squibb36 participantsStarted Oct 2022

Phoenix, Arizona, United States • Costa Mesa, California, United States • Orange, California, United States +29 more locations

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Lung Cancer Trials in Other Cities

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Phase Ib of L-NMMA and Pembrolizumab

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Study of LP-184 in Patients With Advanced Solid Tumors

Pulmonary Rehabilitation Before Lung Cancer Resection

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

Other Conditions in Houston